Shares of Summit Therapeutics (NASDAQ:SMMT) ended five straight sessions of gains on Friday as the stock lost ~35%, ...

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...